Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
anti-cd19 car-t cells | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] leukemia[MeSHID:D007938] T-Lymphocyte[MeSHID:D013601] Lymphoma[MeSHID:D008223] |
NA | phase 1 | unknown |
anti-cd19 car-t cells | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Chronic Lymphocytic Leukemia[MeSHID:D015451] T-Lymphocyte[MeSHID:D013601] |
NA | phase 1/2 | unknown |
anti-cd19 car-t cells | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] B-Cell Lymphomas[MeSHID:D016393] T-Lymphocyte[MeSHID:D013601] |
NA | phase 1/2 | unknown |
anti-cd19 car-t cells | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] leukemia[MeSHID:D007938] T-Lymphocyte[MeSHID:D013601] Lymphoma[MeSHID:D008223] |
NA | phase 1/2 | unknown |
anti-cd19 car-t cells | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Leukemia Prolymphocytic B-Cell[MeSHID:D054403] T-Lymphocyte[MeSHID:D013601] Malignant lymphoma lymphocytic intermediate differentiation diffuse[MeSHID:D020522] Diffuse Large B-Cell Lymphoma[MeSHID:D016403] Chronic Lymphocytic Leukemia[MeSHID:D015451] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] Lymphoma Follicular[MeSHID:D008224] |
NA | phase 1/2 | unknown |
anti-cd19 car-t cells | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Leukemia Prolymphocytic B-Cell[MeSHID:D054403] T-Lymphocyte[MeSHID:D013601] Malignant lymphoma lymphocytic intermediate differentiation diffuse[MeSHID:D020522] Diffuse Large B-Cell Lymphoma[MeSHID:D016403] Chronic Lymphocytic Leukemia[MeSHID:D015451] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] Lymphoma Follicular[MeSHID:D008224] |
NA | phase 1 | unknown |
anti-cd19 car-t cells | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] B-Cell Lymphomas[MeSHID:D016393] T-Lymphocyte[MeSHID:D013601] |
NA | phase 1 | unknown |
anti-cd19 car-t cells | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Chronic Lymphocytic Leukemia[MeSHID:D015451] T-Lymphocyte[MeSHID:D013601] |
NA | phase 1 | unknown |
click here to return to the previous page |